Analyst Reports Day Trading Economy Finance Health Care BioNTech & Cardiol Therapeutics – on the verge of a breakout BioNTech and Pfizer suffers a defeat in a patent dispute, and Cardiol Therapeutics expects significant topline results from a Phase II study. Stefan Feulner5 mins22 May 2024 15:00 (EST)
